Consistent with previous research (Abo-Elmaaty et al. 2020; Habib et al. 2021), this study demonstrated that CIS administration in mice caused a significant increase in MDA levels in both the liver and kidneys, accompanied by a substantial reduction in GSH levels as well as SOD and CAT activities compared to the control group. Here, SOD1 is linked to in situ carcinoma.